CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory multiple myeloma.

Sosana Delimpasi, Hang Quach, Michele Cavo, P. Joy Ho, Cindy Lee, Armando Santoro, Rik Schots, Philip Vlummens, Dok Hyun Yoon, Sung-Soo Yoon, Cedric Dos Santos, Divya Samineni, Jiangeng Huang, Kristin Wehrman, Upen Patil, Semira Sheikh, Meletios A. Dimopoulos

Onderzoeksoutput: Meeting abstract (Journal)

Vingerafdruk

Duik in de onderzoeksthema's van 'CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory multiple myeloma.'. Samen vormen ze een unieke vingerafdruk.

Medicine & Life Sciences